本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Akero Therapeutics

53.84
+0.18000.34%
盘后53.890.0500+0.09%19:52 EDT
成交量:157.62万
成交额:8,468.68万
市值:43.07亿
市盈率:-14.24
高:53.87
开:53.67
低:53.63
收:53.66
52周最高:58.40
52周最低:21.34
股本:7,998.90万
流通股本:6,777.24万
量比:0.33
换手率:2.33%
股息:- -
股息率:- -
每股收益(TTM):-3.7801
每股收益(LYR):-3.7544
净资产收益率:-31.14%
总资产收益率:-20.36%
市净率:4.20
市盈率(LYR):-14.34

数据加载中...

2023/03/29

重要事件披露

8-K - Current report
2023/03/17

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/17

重要事件披露

8-K - Current report
2023/03/17

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/17

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/04

重要事件披露

8-K - Current report
2022/11/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/09/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/16

重要事件披露

8-K - Current report
2022/09/15

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/13

重要事件披露

8-K - Current report
2022/08/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]